Clinical Trials Browser

Completed × Metastatic Castration-Resistant Prostate Cancer × sapanisertib × Clear all

NCT02091531 2019-11-21

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Phase 2 Completed

9 enrolled 10 charts

Metastatic Castration-Resistant Prostate Cancer